■评估高龄患者近视性黄斑变性(MMD)的患病率。
■基于人口的乌拉尔非常老研究(UVOS)包括1882名年龄≥85岁的合格居民中的1526人(81.1%)。930名(60.9%)人的可评估眼底图像(平均年龄,88.6±2.7年)。MMD定义为黄斑斑片状萎缩(即,病理性近视研究组定义的MMD阶段3和4)。
■MMD患病率为930人中的21人(2.3%;95%CI,1.3-3.3),10名个体(1.1%;95%CI,0.4-1.7)患有MMD3期疾病,11名参与者(1.2%;95%CI,0.5-1.9)患有MMD4期疾病。在MMD3期和4期中,双眼中度至重度视力障碍的患病率为10人中的4人(40%;95%CI,31-77)和11人中的7人(64%;95%CI,30-98),分别,双眼盲的患病率为10人中的2人(20%;95%CI,0-50)和11人中的3人(27%;95%CI,0-59),分别。在轻度近视(轴向长度,24.0至<24.5mm),中度近视(轴长,24.5至<26.5mm),和高度近视(轴向长度,≥26.5mm),右眼的MMD患病率为46眼的0(0%),40只眼中的3只眼(8%;95%CI,0-16),9人中的7人(78%;95%CI,44-100),左眼MMD患病率分别为48只眼中的1只眼(2%;95%CI,0-6),36只眼中的4只眼(11%;95%CI,0-22),4只眼中的3只眼(75%;95%CI,0-100),分别。在多变量分析中,MMD患病率较高(赔率比,8.89;95%CI,3.43-23.0;P<0.001)和更高的MMD分期(β,0.45;B,19;95%CI,0.16-0.22;P<0.001)与较长的轴向长度相关,但与任何其他眼部或全身参数无关。
■非常老的个体的MMD患病率(第3阶段和第4阶段)每增加毫米轴向长度增加8.89倍,在高度近视的眼睛中患病率≥75%。在老年,高度近视个体最终发展为MMD并伴有明显视力障碍的风险很高.
UNASSIGNED: To assess the prevalence of myopic macular degeneration (MMD) in very old individuals.
UNASSIGNED: The population-based Ural Very Old
Study (UVOS) included 1526 (81.1%) of 1882 eligible inhabitants aged ≥85 years. Assessable fundus images were available for 930 (60.9%) individuals (mean age, 88.6 ± 2.7 years). MMD was defined by macular patchy atrophies (i.e., MMD stage 3 and 4 as defined by the Pathologic Myopia
Study Group).
UNASSIGNED: MMD prevalence was 21 of 930 (2.3%; 95% CI, 1.3-3.3), with 10 individuals (1.1%; 95% CI, 0.4-1.7) having MMD stage 3 and 11 participants (1.2%; 95% CI, 0.5-1.9) MMD stage 4 disease. Within MMD stage 3 and 4, prevalence of binocular moderate to severe vision impairment was 4 of 10 (40%; 95% CI, 31-77) and 7 of 11 (64%; 95% CI, 30-98), respectively, and the prevalence of binocular blindness was 2 of 10 (20%; 95% CI, 0-50) and 3 of 11 (27%; 95% CI, 0-59), respectively. In minor myopia (axial length, 24.0 to <24.5 mm), moderate myopia (axial length, 24.5 to <26.5 mm), and high myopia (axial length, ≥26.5 mm), MMD prevalence in the right eyes was 0 of 46 eyes (0%), 3 of 40 eyes (8%; 95% CI, 0-16), and 7 of 9 (78%; 95% CI, 44-100), respectively; MMD prevalence in the left eyes was 1 in 48 eyes (2%; 95% CI, 0-6), 4 of 36 eyes (11%; 95% CI, 0-22), and 3 of 4 eyes (75%; 95% CI, 0-100), respectively. In multivariable analysis, a higher MMD prevalence (odds ratio, 8.89; 95% CI, 3.43-23.0; P < 0.001) and higher MMD stage (beta, 0.45; B, 19; 95% CI, 0.16-0.22; P < 0.001) were correlated with longer axial length but not with any other ocular or systemic parameter.
UNASSIGNED: MMD prevalence (stages 3 and 4) in very old individuals increased 8.89-fold for each mm axial length increase, with a prevalence of ≥75% in highly myopic eyes. In old age, highly myopic individuals have a high risk of eventually developing MMD with marked vision impairment.